Evidence map›Paper›PMID 20844761›Full record

ArticlePloS one2010

LYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner.

Georgi L Lukov, Margaret A Goodell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Georgi L LukovDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
Margaret A Goodell
Baylor College of Medicine · US

Funding

Tissue ResourceP50CA126752 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, HELEN E HESLOP · 2007 to 2026
$51.4M
Validation of Suicide Strategies for Cellular TherapyU54HL081007 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BRENNER, MALCOLM K. · 2005 to 2009
$10.2M
MUSCLE-DERIVED HEMATOPOIETIC STEM CELLSR01DK058192 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2000 to 2010
$3.6M
NCI NIH HHS P50 CA126752NCI NIH HHS P50CA126752NHLBI NIH HHS HL081007NHLBI NIH HHS U54 HL081007NIDDK NIH HHS DK58192NIDDK NIH HHS R01 DK058192
6 · The paper itself

Abstract

backgroundThe Lymphoblastic leukemia 1 (LYL1) gene is a proto-oncogenic transcription factor found upregulated in patients with T-cell acute lymphoblastic leukemia (T-cell ALL). Initially, the upregulation was described to be as a result of a translocation. However, further studies revealed that transcriptional upregulation of LYL1could also occur without translocations. In addition, post-translational mechanisms, such as protein degradation could influence LYL1 expression as well. METHODOLOGY/PRINCIPAL

findingsIn this study, we considered possible post-translational regulation of Lyl1, and investigated fundamental mechanisms governing LYL1 degradation in cell-based culture assays. We identify a PEST sequence motif located in the N-terminus of LYL1, which determines the efficiency of LYL1 degradation by the proteasome. The absence of the PEST degradation site leads to accumulation or upregulation of LYL1. We also show that LYL1 is phosphorylated by MAPK at S36, and determined that proteasomal degradation of LYL1 occurs in a phosphorylation-independent manner. CONCLUSIONS/SIGNIFICANCE: Understanding LYL1 degradation is a step forward not only towards deciphering the normal function and regulation of LYL1, but could suggest post-translational mechanisms for upregulation of LYL1 that may contribute to its oncogenic role.

Indexed as

Amino Acid MotifsAmino Acid SequenceBasic Helix-Loop-Helix ProteinsCell LineHumansMitogen-Activated Protein Kinase KinasesMolecular Sequence DataNeoplasm ProteinsPhosphorylationProteasome Endopeptidase ComplexSequence AlignmentBasic Helix-Loop-Helix ProteinsLYL1 protein, humanMitogen-Activated Protein Kinase KinasesNeoplasm ProteinsProteasome Endopeptidase Complex

Identifiers

PMID20844761
PMCPMC2937031
OpenAlexW2067788144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.